Categories AlphaGraphs, Earnings, Finance, LATEST, U.S. Markets News

Financial giant Morgan Stanley posts Q4 earnings below market expectations

Volatile global market environment pushed fourth-quarter revenue and profit of Morgan Stanley (MS) below Street expectations, as the financial giant reported its results before the market opened on Thursday, January 17.

The company saw net revenues fall to $8.5 billion for the fourth quarter, down from $9.5 billion a year ago.

For the quarter, net income applicable to Morgan Stanley was $1.5 billion or $0.80 per diluted share, up from $643 million or $0.26 per diluted share.

Analysts expected earnings of $0.90 per share on revenue of $9.61 billion.

Morgan Stanely fourth quarter 2018 earnings infographic

In the three-month period, Morgan Stanley recorded an intermittent net discrete tax benefit of $111 million or $0.07 per diluted share, regarding the resolution of multi-jurisdiction tax examinations. While in the same period a year ago, an intermittent net discrete tax provision of $1.0 billion or a loss of $0.58 per diluted share affected the results due to the Tax Cuts and Jobs Act.

Compensation expense was $3.8 billion for the quarter, down from $4.3 billion a year ago on lower net revenues. Non-compensation expenses were $2.9 billion, up from $2.8 billion a year ago.

The annualized return on average common equity was 7.7% and the annualized return on average tangible common equity was 8.8% in the current quarter.

CEO James P. Gorman said “we delivered higher annual returns, producing an ROE of 11.8% and ROTCE of 13.5%, as we continued to invest in our businesses. While the global environment remains uncertain, our franchise is strong and we are well positioned to pursue growth opportunities and serve our clients.”

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top